Find Academic Supervisors

Joel GohView profile

Associate Professor

• Health services and systems
• Transportation, logistics and supply chains
• Operations research
• +6 more

Joel Goh is Associate Professor at the Department of Analytics and Operations, NUS Business School, National University of Singapore. He serves as Director of the J.Y. Pillay Comparative Asia Research Centre (under NUS Global Asia Institute) and PhD Program Director at the Institute of Operations Research and Analytics (IORA). Previously, he was Assistant Professor at Harvard Business School (2014-2017) and Visiting Scholar (2017-2022). BSc, MSc, PhD in Operations, Information, and Technology from Stanford University His research focuses on healthcare analytics (preventing health conditions, hospital operations, frailty assessment), supply chain analytics (digital business models, platform leakage), and service platform operations (hospital-at-home programs, incentive design). He co-created the Robust Optimization Made Easy (ROME) software. Recent publications analyze workplace psychological safety (2024), hospital-at-home models (2024), and platform leakage dynamics (2023). His work spans 18+ journals with 740+ citations for burnout cost studies (2022) and 606+ citations for physician well-being research (2017). Teaching Honors : 2023: Best MBA Teaching & Skinner Innovation Award 2021: NUS Annual Teaching Excellence Award 2020: Early Career Research Excellence Award & 40 Under 40 Best MBA Professors Advising & Grants : Served as PhD Program Director. Received NUS Start-Up Grant R-314-000-110-133 (2021) and Humanities & Social Sciences Fellowship (2021). Editorial roles include Associate Editor at Management Science , Manufacturing & Service Operations Management , and Senior Editor at Production and Operations Management .

Allison Ross EckardView profile

Professor

• HIV-related cardiometabolic complications
• Antiretroviral therapy optimization
• Pediatric infectious diseases
• +7 more

Allison Ross Eckard, MD is Professor in the Departments of Pediatrics and Medicine at the Medical University of South Carolina (MUSC) College of Medicine, serving as Division Chief for Pediatric Infectious Diseases and Director of MUSC's Ryan White Pediatric HIV Clinic and HIV Transition Clinic. She maintains an adjunct faculty position at Emory University and holds board certification in Pediatrics and Pediatric Infectious Diseases. Her primary research focuses on metabolic, cardiovascular, and nutritional complications of chronic HIV and antiretroviral therapy across age groups, with emphasis on inflammation's role in comorbidities like cardiovascular disease and bone disorders. Current investigations include NIH R01-funded research on interventions for weight gain and abdominal fat in HIV, vitamin D supplementation, and statin therapy. She has published nearly 60 peer-reviewed papers on HIV pathogenesis and treatment optimization. Dr. Eckard co-chairs the DHHS panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children and serves on the DHHS panel for Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV . Her clinical work specializes in comprehensive HIV care for children through young adults, with particular focus on adolescent/young adult transition issues and global health initiatives through Lespwa Timoun in Haiti. Recent efforts include developing COVID-19 treatment guidelines for children and school safety protocols. HIV Specialist certification (American Academy of HIV Medicine) Fellow, Infectious Diseases Society of America Fellow, Pediatric Infectious Diseases Society Fellow, HIV Medical Association Member, HIV Medical Association's 'Ending the HIV Epidemic' working group She leads MUSC's HIV education initiatives and serves as inpatient consultant for pediatric infectious diseases, with advanced training in tropical medicine. Her NIH-funded research examines targeted interventions to minimize comorbidity development in HIV, while her clinical leadership spans the Ryan White HIV program, transition clinics, and global health partnerships.

Terry C. LansdownView profile

Associate Professor

• Human Factors
• Transport Safety
• Driver Behavior
• +7 more

Terry C. Lansdown is an Associate Professor in the School of Social Sciences and Department of Psychology at Heriot-Watt University. His expertise lies in Human Factors, particularly focusing on driver safety, workload management, and attentional distraction in transportation contexts. Prior to his academic role, he worked as a senior researcher at the Transport Research Laboratory, contributing to numerous EU-funded and government-sponsored projects. His research integrates ergonomics principles with real-world applications, addressing issues like automated driving systems, social distractions in vehicles, and occupational health in construction industries. Key research interests include: Driver behavior and road safety Human factors in automated systems Workload and attentional demands in complex tasks Health and safety in small-to-medium enterprises (SMEs) He has led studies on pandemic response strategies, such as the CHARIS project analyzing behavioral adherence during the COVID-19 crisis. Lansdown’s work frequently bridges psychological theory with practical interventions, including text messaging campaigns to improve construction worker safety and experimental designs to evaluate automation failure responses. Collaborations span academic and industrial sectors, with publications addressing topics ranging from UV exposure in outdoor workers to the cognitive impacts of in-vehicle distractions. His contributions align with UN Sustainable Development Goals related to health (SDG 3) and sustainable cities (SDG 11).

• Public Health
• Health Promotion
• Behavioral Science
• +10 more

Rik Crutzen is a Full Professor at the Faculty of Health, Medicine and Life Sciences, Maastricht University, specializing in health promotion and digital interventions. His research focuses on leveraging technology to improve health behaviors across diverse populations, including adolescents, older adults, and immigrant communities. He leads projects in the CAPHRI research group for Promoting Health & Personalised Care. Research trends include: Digital health innovations (e.g., helplines, apps, algorithms) Chronic disease management (post-COVID-19, dementia risk) Health equity in immigrant populations (cervical cancer, maternal care) Behavioral interventions (physical activity, sleep, STI prevention) Systematic reviews and mixed-methods studies He has supervised 22 academic works and contributed to datasets on activity patterns and sleep-activity correlations. His work spans public health policy, health education, and technology integration.

• Statistical Reinforcement Learning
• Mobile Health (mHealth)
• Clinical Trials
• +3 more

Susan A. Murphy is the Mallinckrodt Professor of Statistics and of Computer Science at Harvard University, with affiliations to the Kempner Institute. She leads the Statistical Reinforcement Learning Lab, focusing on developing algorithms to inform sequential decision-making in health, particularly for Just-in-Time Adaptive Interventions (JITAIs) and micro-randomized trials (MRTs). Her work is funded by NIH institutes, including NIDA, NHLBI, and NIBIB. Dr. Murphy has been awarded a MacArthur Fellowship (2013) and is a member of the National Academy of Medicine (2014) and the National Academy of Sciences (2016). Her research integrates statistical methods with computer science techniques to optimize mobile health interventions. She collaborates with d3Lab and mDOT on projects like HeartSteps and Sense2Stop, evaluating real-time treatment policies. Notable contributions include advancing MRT designs, sample size calculations, and reinforcement learning algorithms for personalized healthcare. Dr. Murphy advises a large team of postdocs, graduate students, and undergraduates, many of whom hold academic and industry roles globally. She emphasizes engagement in digital interventions, balancing personalization with ethical considerations. Her lab’s work spans algorithm development, clinical trial design, and causal inference, aiming to improve health outcomes through adaptive interventions.

Huining LiView profile

Assistant Professor

• Mobile Computing
• Internet of Things
• Cybersecurity
• +5 more

Huining Li is an Assistant Professor in the Department of Computer Science at North Carolina State University . Her research focuses on Internet of Things (IoT) , cybersecurity , and mobile computing , with a specialized emphasis on mobile health (mHealth) technologies. Education: Ph.D. in Computer Science and Engineering from University at Buffalo (2024). Her work addresses privacy-preserving sensing mechanisms , biomarker measurement , and fairness in dynamic mobile environments , developing systems for chronic wound care, Parkinson’s disease management, and mental health therapy. Recent publications highlight innovations in mmWave biometrics , machine learning for health diagnostics , and non-contact monitoring . Scientific Awards: Best Paper Awards (SenSys 2019, BodyNet 2021, ICHI 2022) Best Paper Candidate (SenSys 2022) Harold O. Wolf Achievement Award (2024) EECS Rising Star (2023) NIH mHealth Training Institute Scholar (2025) She teaches courses in Mobile Health Systems and Applications and Computer Networks , and actively serves on NSF panels , TPC committees (ACM MobiSys, IEEE-EMBS BSN), and as Associate Editor for journals like Elsevier Smart Health.

Jiaqi GongView profile

Associate Professor

• Artificial Intelligence
• Smart and Connected Health
• Cyber-Physical Systems
• +13 more

Dr. Jiaqi Gong serves as Associate Professor in Computer Science and Adjunct Associate Professor in Mechanical Engineering at The University of Alabama's College of Engineering, while directing the Alabama Center for the Advancement of Artificial Intelligence. His academic foundation includes: B.S. in Engineering, China University of Geoscience (2004) Ph.D. in Engineering, Huazhong University of Science and Technology (2010) Dr. Gong's research pioneers human-AI convergence through cyber-physical systems and smart health technologies, developing mobile/wearable platforms to enhance human perceptual, cognitive, and physical capabilities. His work spans artificial intelligence, machine learning, computer vision, and IoT with applications in healthcare, environmental monitoring, and education. The Sensor-Accelerated Intelligent Learning (SAIL) laboratory he founded drives innovation in behavior change interventions, human movement modeling, and educational data mining. Recent publications reveal strong interdisciplinary trends: healthcare AI dominates with medication adherence prediction and surgical classification systems, while environmental applications feature flood-risk communication and drought analysis. His work increasingly integrates generative AI and LLMs across domains, demonstrating methodological innovation in federated learning, knowledge graphs, and explainable storytelling frameworks. Notable recognitions include: Best Student Paper Award, IEEE/ACM Connected Health Conference (2022) Best Student Paper Award, Body Sensor Networks Conference (2019) Data Challenge Win, IEEE Biomedical Health Informatics (2018) Best Paper Award, Body Area Networks Conference (2014) Best Demonstration Award, IEEE Wireless Health Conference (2014) Dr. Gong leads significant funded projects including a $2M CDC/NIOSH grant for first responder safety and $3M NSF funding for hydrologic research. As SAIL laboratory director, he mentors students in developing clinically deployed technologies for multiple sclerosis, dementia, and mental health. Future work focuses on scaling AI applications in chronic disease management and climate resilience through the Alabama AI Center. The SAIL laboratory (founded 2017) operates as a multidisciplinary hub developing wearable/mobile systems for health applications, with active collaborations across medical clinics and engineering departments for real-world deployment of behavior change interventions and movement analysis tools.

Ashli Owen-SmithView profile

Researcher

• Mental Health
• Behavioral Science
• Trauma
• +6 more

Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .

Tim JenkinsonView profile

Professor

• Private Equity
• Initial Public Offerings (IPOs)
• Institutional Asset Management
• +4 more

Tim Jenkinson is a Professor of Finance at the Saïd Business School, University of Oxford. He holds dual roles as a Professorial Fellow at Keble College and a Research Associate at the European Corporate Governance Institute. His expertise spans private equity, IPOs, and institutional asset management, with a focus on empirical research leveraging unique industry data. Education: B.A. in Economics from the University of Cambridge, Thouron Fellowship at the University of Pennsylvania, DPhil in Economics from the University of Oxford. Research Interests : Tim’s work examines private equity performance persistence, IPO pricing dynamics, and regulatory impacts on financial markets. His studies have been published in top journals like Journal of Financial Economics and Management Science . Key Contributions : Director of the Oxford Private Equity Institute, founder of the Private Equity Research Consortium, and frequent keynote speaker at global finance events. His research has won major awards, including the Harry Markowitz Prize (2016) and Commonfund Prize (2015). Engagement & Teaching : Teaches entrepreneurial finance to MBA/EMBA students and runs the Oxford Private Equity Programme. Recognized with the 2014 'Best Elective Teacher' award. Also serves on valuation committees for Schroder British Opportunities Trust and Oxford University Endowment Management. Professional Roles : Partner at Oxera (economic consultancy), former UK Treasury Select Committee advisor, and expert witness in high-profile litigation. His work bridges academia and practice, influencing policy and industry standards. Labs & Initiatives : Leads the Oxford Private Equity Institute and collaborates with the Oxford-Hyundai Motor Group Foresight Centre. Active in shaping future research through the Private Equity Research Consortium.

• Medical Informatics
• Artificial Intelligence in Healthcare
• Healthcare Data Integration
• +7 more

Prof. Martin Boeker is a Professor of Medical Informatics at the Technical University of Munich (TUM), affiliated with the TUM School of Medicine and Health. His work focuses on advancing healthcare through AI-driven solutions, interoperability frameworks, and precision medicine initiatives. Key projects include the German Medical Text Corpus (GeMTeX) and the MIRACUM DIFUTURE Alignment Hub. Expertise: Medical Informatics, AI in Healthcare, Federated Learning, Health Data Integration Key Contributions: FHIR-based systems, clinical decision support, patient-centered outcomes research Leadership: Director of the Institute for AI and Informatics in Medicine at TUM Hospital Right of the Isar Research emphasizes bridging clinical practice and data science through projects like modular health crawlers, automated guideline adherence monitoring, and cross-institutional medical NLP solutions. His work spans oncology informatics, rare disease management, and pandemic response data ecosystems. Recent articles highlight innovations in digital twins for precision oncology, federated analysis in oncology, and German-language medical NLP challenges. He collaborates internationally on EHR standardization and healthcare interoperability, contributing to the Medical Informatics Initiative (MII) and pandemic evidence ecosystems. Grants and collaborations involve the German Federal Ministry of Education and Research, European initiatives, and industry partnerships. Educational efforts focus on training future medical informatics professionals through MII competency programs.

• Information Systems
• Healthcare IT
• Knowledge Management
• +5 more

Atreyi Kankanhalli is a Professor at the National University of Singapore, specializing in Information Systems with a focus on knowledge management, healthcare IT, and digital innovation. Their research spans over three decades, with prolific contributions in top journals like MIS Quarterly, Journal of AIS, and Information & Management. They have co-authored over 150 papers addressing topics such as crowdsourcing, online communities, and the impact of AI on scholarly practices. Notable work includes studies on user adherence to health apps, innovation in public sector data utilization, and the ethical challenges of generative AI in peer review. Kankanhalli has also led research on global virtual teams and digital technologies' role in social justice, reflecting a commitment to both technical and societal dimensions of information systems. Education & Background: While specific degree details are not provided, their extensive publication history and academic roles imply advanced qualifications in Information Systems or related fields. They have collaborated with global researchers across institutions like NUS, University of Illinois, and Singapore Management University. Research Themes: Core areas include digital health interventions (e.g., fitness app adherence), organizational innovation via open data and crowdsourcing, and the socio-technical challenges of AI in academia. Their work often bridges theoretical frameworks with practical applications, such as healthcare decision support systems and policy-driven technology adoption. Impact & Influence: As an editorial board member and frequent conference contributor (e.g., ICIS, PACIS), Kankanhalli shapes the field's research agenda. Their recent focus on generative AI's implications highlights proactive engagement with emerging technologies' ethical and methodological challenges.

Sarah Woolf-KingView profile

Adjunct Assistant Professor

• Clinical Psychology
• HIV/AIDS
• Substance Use
• +9 more

Sarah Woolf-King is an Assistant Adjunct Professor in the Department of Medicine at the University of California, San Francisco (UCSF), School of Medicine. She is a licensed clinical psychologist (CA PSY28178) whose research bridges psychology and health, with a strong focus on substance use, HIV, and mental health in families affected by congenital heart defects. Her educational background includes a B.S. in Psychology from Arizona State University (2002), an M.S./Ph.D. in Clinical Psychology from Syracuse University (2010), an M.P.H. in Epidemiology from UC Berkeley (2011), a clinical internship in Behavioral Medicine at VA Palo Alto (2010), and a T32 Postdoctoral Fellowship at UCSF’s Center for AIDS Prevention Studies (2013). Dr. Woolf-King’s research centers on two primary areas: (1) the impact of alcohol use on HIV treatment and prevention, particularly among HIV-positive men who have sex with men (MSM) and in East African populations, and (2) the mental health needs of parents of children with critical congenital heart defects (CHD). Her work employs diverse methodologies, including daily data collection, qualitative interviews, randomized trials, and biomarker validation (e.g., PEth). She aims to develop integrated behavioral interventions to improve health outcomes for individuals and families coping with chronic illness. Her recent publications (2023–2025) reflect a consistent focus on alcohol use in the context of HIV, with studies on counseling interventions, digital screening, remote biomarker collection, and behavioral mechanisms. There is also growing attention to mental health in vulnerable populations, including college students and parents of children with genetic or cardiac conditions. Her work is increasingly interdisciplinary, combining psychology, epidemiology, public health, and global health. Scientific Awards: Hellman Fellow, Hellman Fellows Fund (2015–2017) Mentored Research Scientist Development Award (K01), NIH/NIAAA (2013–2018) Loan Repayment Program in Clinical Research, NIH/NIAAA (2011–2016) Ruth L. Kirschstein National Research Service Award (F31), NIH/NIAAA (2008–2010) Mentored Scientist Award in HIV/AIDS, UCSF CFAR (2012–2014) Dr. Woolf-King has served as Principal Investigator on NIH-funded projects, including an R34 grant for a brief ACT intervention for HIV-positive hazardous drinkers and a K01 grant on alcohol and sexual risk behavior. She collaborates extensively with researchers at UCSF and in East Africa, particularly Uganda. While her adjunct title suggests a part-time or non-tenure-track role, she maintains an active research program with significant grant support and a robust publication record. There is no indication of retirement or former staff status.

• Sepsis
• Infectious Diseases
• Critical Care Medicine
• +3 more

Dr. Justin Belsky is an Assistant Professor of Emergency Medicine at Yale School of Medicine, serving as the COVID-19 Safety Officer and Co-Director of Resident Research in Emergency Medicine. He holds an MD from Wayne State University School of Medicine (2011) and an MPH from Harvard School of Public Health (2016). His research focuses on sepsis diagnosis and treatment, including biomarkers, clinical trials, and risk stratification tools. He led the Yale site for the VICTAS trial evaluating vitamin C, thiamine, and hydrocortisone in septic shock. Dr. Belsky directs the Yale Emergency Medicine Specimen Biobank, collecting samples from critically ill patients for future research. His awards include the Partners in Excellence Team Award (2016) and an Outstanding Poster Award (2015). He is actively involved in resident research training and clinical guideline adherence studies. Education: MD: Wayne State University School of Medicine (2011) Emergency Medicine Residency: Henry Ford Hospital (2014) Research Fellowship: Massachusetts General Hospital (2016) MPH: Harvard School of Public Health (2016) Research Interests: Early sepsis identification and treatment Biomarker development for critical illness Fluid management strategies in septic shock Micronutrient therapies in sepsis Emergency department quality improvement Recent Work Focus: Fluid resuscitation protocols and guideline adherence Long-term outcomes of sepsis therapies Actin cytoskeleton as a sepsis biomarker Antibiotic timing in sepsis Awards: 2016: Sepsis Care Redesign, Partners in Excellence Team Award 2015: Outstanding Poster Award (Shock Symposium) Grants & Mentorship: Principal investigator for CLOVERS trial (fluid management in sepsis) Co-Director of Yale’s Emergency Medicine Research Training Program Leadership in resident research mentorship and biobank initiatives

• Non-Communicable Diseases
• Global Health
• Health Services Research
• +3 more

Dr. Jeremy I. Schwartz is an Associate Professor at Yale School of Medicine (Department of Medicine) and Yale School of Public Health (Department of Chronic Disease Epidemiology). He specializes in non-communicable diseases (NCDs), global health, and digital health interventions. As Firm Chief of Yale Primary Care Residency Program and Director of the Faculty Network Program at the Yale Institute for Global Health, he leads initiatives to improve healthcare delivery in low-resource settings. He co-founded the Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), collaborating with Ugandan institutions to address fragmented NCD care. His research focuses on hypertension, diabetes, and heart failure management in Uganda, leveraging mobile health (mHealth) tools. He also directs the 'Topics in Global Medicine' course at Yale, training future healthcare leaders in global health challenges. Education: MD from University of Rochester School of Medicine & Dentistry (2006), BS from Cornell University (2000). Honors include the Doran J. Stevens Prize (2006), Gold Humanism Honor Society (2006), and Alpha Omega Alpha (2005). Key roles: Medical Director of the Eastern Caribbean Health Outcomes Research Network (ECHORN), Co-Director of UINCD, and affiliated faculty at the Yale Institute for Global Health and Center for Interdisciplinary Research on AIDS. His work emphasizes interdisciplinary collaboration, with a focus on Africa and the Caribbean. Research emphasizes integrated care models, digital health innovations, and policy advocacy for NCDs. Recent projects include adapting mobile health applications for heart failure patients and evaluating cost barriers to essential medicines in Uganda.

Jeffrey T. JensenView profile

Professor

• Contraception
• Reproductive Health
• Translational Research
• +2 more

Jeffrey T. Jensen, M.D., M.P.H., is the Leon Speroff Professor and Vice Chair for Research in the Department of Obstetrics and Gynecology at Oregon Health & Science University (OHSU). He holds joint appointments as Professor of Public Health and Preventive Medicine and serves as a Core Scientist at the Oregon National Primate Research Center (ONPRC). Dr. Jensen completed his medical degree at Emory University, a Master of Public Health at the University of Washington, and residency training at OHSU. Research Focus: Dr. Jensen leads translational and clinical research programs focused on contraceptive innovation. His work emphasizes nonhuman primate models to develop: Novel contraceptive agents targeting oocyte-specific pathways Non-surgical permanent contraception methods Optimized emergency contraception for diverse populations He directs OHSU's Women’s Health Research Unit and the Gates Foundation-funded Oregon Permanent Contraception Research Center (OPERM). Recent Publications: His 15 most recent articles (2023-2025) demonstrate concentrated expertise in: Advanced hormonal contraceptive formulations (IUDs, vaginal rings, oral agents) Weight-adjusted dosing strategies for emergency contraception Biomarker validation for contraceptive efficacy monitoring Real-world assessment of bleeding pattern management Leadership & Collaboration: Dr. Jensen is Principal Investigator of the NICHD Contraception Clinical Trials Network and collaborates with global health organizations (CONRAD, FHI360, Population Council). He serves as Deputy Editor for the journal Contraception and consults for multiple pharmaceutical companies on product development.